SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
Yesterday 1:32 PM View: | Loeillot Olivier Chief Executive Officer Director | Repligen Corp. (RGEN) | 20-Nov-24 | Payment of Exercise | 861 | $123.41 | $106,256.00 | (3%) 33.42K to 32.56K | |
Yesterday 2:10 PM View: | Garland Jason K CFO | Repligen Corp. (RGEN) | 20-Nov-24 | Payment of Exercise | 367 | $123.41 | $45,291.50 | (5%) 8.04K to 7.68K | |
20-Nov-24 2:29 PM View: | Muir Glenn P Director | Repligen Corp. (RGEN) | 19-Nov-24 | Option Exercise | 19,000 | $36.29 | $689,510.00 | 143% 13.28K to 32.28K | |
12-Sep-24 11:35 AM View: | Hunt Anthony Director | Repligen Corp. (RGEN) | 10-Sep-24 | Option Sale | 10,000 | $145.37 | $1,453,710.00 | (6%) 162.03K to 152.03K | |
12-Sep-24 11:35 AM View: | Hunt Anthony Director | Repligen Corp. (RGEN) | 10-Sep-24 | Sale | 12,191 | $145.37 | $1,772,220.00 | (8%) 152.03K to 139.84K | |
12-Sep-24 11:35 AM View: | Hunt Anthony Director | Repligen Corp. (RGEN) | 10-Sep-24 | Option Exercise | 10,000 | $33.87 | $338,700.00 | 7% 152.03K to 162.03K | |
04-Sep-24 7:25 PM View: | Hunt Anthony Director | Repligen Corp. (RGEN) | 03-Sep-24 | Disposition | 13,146 | -- | -- | (8%) 165.18K to 152.03K | |
04-Sep-24 8:41 PM View: | Loeillot Olivier Chief Executive Officer Director | Repligen Corp. (RGEN) | 03-Sep-24 | Grant | 17,631 | -- | -- | 112% 15.79K to 33.42K | |
01-Aug-24 8:47 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 01-Aug-24 | Sale | 4,465 | $165.67 | $739,717.00 | (19%) 23.73K to 19.26K | |
01-Aug-24 5:04 PM View: | Muir Glenn P Director | Repligen Corp. (RGEN) | 01-Aug-24 | Option Exercise | 5,000 | $36.29 | $181,450.00 | 60% 8.28K to 13.28K | |
14-Jun-24 5:41 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 14-Jun-24 | Private Purchase | 2,000 | $124.08 | $248,160.00 | 1% 163.18K to 165.18K | |
14-Jun-24 5:33 PM View: | Dawes Karen A Director | Repligen Corp. (RGEN) | 14-Jun-24 | Option Exercise | 2,953 | $67.71 | $199,948.00 | 3% 85.22K to 88.17K | |
14-Jun-24 5:42 PM View: | Barthelemy Nicholas Director | Repligen Corp. (RGEN) | 14-Jun-24 | Private Purchase | 1,200 | $125.45 | $150,540.00 | 35% 3.47K to 4.67K | |
14-Jun-24 6:07 PM View: | Madaus Martin D Director | Repligen Corp. (RGEN) | 14-Jun-24 | Private Purchase | 1,615 | $124.94 | $201,776.00 | 54% 3.01K to 4.62K | |
22-May-24 5:14 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 21-May-24 | Sale | 20,072 | $168.26 | $3,377,280.00 | (11%) 183.25K to 163.18K | |
20-May-24 7:30 PM View: | Pax Margaret Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 701 | -- | -- | 762% 92 to 0.79K | |
20-May-24 7:32 PM View: | Mhatre Rohin Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 701 | -- | -- | 30% 2.35K to 3.05K | |
20-May-24 7:27 PM View: | Konstantinov Konstantin Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 701 | -- | -- | 57% 1.22K to 1.92K | |
20-May-24 6:49 PM View: | Muir Glenn P Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 701 | -- | -- | 9% 7.58K to 8.28K | |
20-May-24 6:50 PM View: | Dawes Karen A Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 803 | -- | -- | < 1% 87.37K to 88.17K | |
20-May-24 6:50 PM View: | Barthelemy Nicholas Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 701 | -- | -- | 25% 2.77K to 3.47K | |
20-May-24 7:51 PM View: | Madaus Martin D Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 701 | -- | -- | 30% 2.31K to 3.01K | |
20-May-24 6:53 PM View: | Eglinton Manner Carrie Director | Repligen Corp. (RGEN) | 16-May-24 | Grant | 701 | -- | -- | 25% 2.79K to 3.49K | |
15-May-24 8:17 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 14-May-24 | Payment of Exercise | 534 | $163.34 | $87,223.60 | (2%) 24.26K to 23.73K | |
15-May-24 8:18 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 14-May-24 | Payment of Exercise | 334 | $163.34 | $54,555.60 | (1%) 27.75K to 27.42K | |
04-Apr-24 5:04 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 02-Apr-24 | Payment of Exercise | 444 | $182.95 | $81,229.80 | (2%) 21.04K to 20.59K | (15%) |
20-Mar-24 4:29 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 18-Mar-24 | Gift | 2,000 | -- | -- | (1%) 185.25K to 183.25K | |
19-Mar-24 6:19 PM View: | Pax Margaret Director | Repligen Corp. (RGEN) | 18-Mar-24 | Grant | 92 | -- | -- | 100% 0 to 92 | |
12-Mar-24 8:24 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 11-Mar-24 | Sale | 2,246 | $193.73 | $435,118.00 | (8%) 26.51K to 24.26K | |
12-Mar-24 8:24 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 11-Mar-24 | Option Exercise | 1,271 | $86.10 | $109,433.00 | 5% 26.51K to 27.78K | |
12-Mar-24 8:24 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 11-Mar-24 | Option Sale | 1,271 | $193.73 | $246,231.00 | (5%) 27.78K to 26.51K | |
11-Mar-24 7:43 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 08-Mar-24 | Option Exercise | 1 | $16.55 | $16.55 | < 1% 201.96K to 201.96K | |
11-Mar-24 7:43 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 08-Mar-24 | Option Sale | 1 | $197.44 | $197.44 | (< 1%) 201.96K to 201.96K | |
11-Mar-24 7:43 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 08-Mar-24 | Sale | 16,706 | $197.44 | $3,298,430.00 | (8%) 201.96K to 185.25K | |
07-Mar-24 4:23 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 1,206 | $195.72 | $236,038.00 | (5%) 22.24K to 21.04K | (8%) |
07-Mar-24 4:22 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 386 | $195.72 | $75,547.90 | (1%) 28.14K to 27.75K | (8%) |
07-Mar-24 4:27 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 386 | $195.72 | $75,547.90 | (1%) 26.89K to 26.51K | (8%) |
07-Mar-24 4:28 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 07-Mar-24 | Payment of Exercise | 2,867 | $195.72 | $561,129.00 | (1%) 204.82K to 201.96K | (8%) |
06-Mar-24 10:00 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 05-Mar-24 | Payment of Exercise | 7,275 | $195.52 | $1,422,410.00 | (3%) 212.1K to 204.82K | (8%) |
06-Mar-24 10:00 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 05-Mar-24 | Payment of Exercise | 22 | $195.52 | $4,301.44 | (< 1%) 22.26K to 22.24K | (8%) |
06-Mar-24 10:00 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 1,111 | $193.99 | $215,523.00 | (< 1%) 213.21K to 212.1K | (9%) |
06-Mar-24 10:00 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 197 | $193.99 | $38,216.00 | (< 1%) 22.46K to 22.26K | (9%) |
06-Mar-24 10:00 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 135 | $193.99 | $26,188.70 | (< 1%) 27.03K to 26.89K | (9%) |
04-Mar-24 9:45 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 04-Mar-24 | Payment of Exercise | 461 | $192.71 | $88,839.30 | (2%) 28.73K to 28.27K | |
04-Mar-24 9:45 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 820 | $191.79 | $157,268.00 | (4%) 23.23K to 22.41K | |
04-Mar-24 9:51 PM View: | Kuriyel Ralf Senior VP, R&D | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 453 | $191.79 | $86,880.90 | (2%) 27.48K to 27.03K | |
04-Mar-24 9:45 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 447 | $191.79 | $85,730.10 | (2%) 29.18K to 28.73K | |
05-Mar-24 8:44 PM View: | Bylund James Chief Operating Officer | Repligen Corp. (RGEN) | 01-Mar-24 | Grant | 50 | -- | -- | < 1% 22.41K to 22.46K | |
04-Mar-24 9:49 PM View: | Hunt Anthony Chief Executive Officer | Repligen Corp. (RGEN) | 01-Mar-24 | Payment of Exercise | 3,322 | $191.79 | $637,126.00 | (2%) 216.53K to 213.21K | |
04-Mar-24 9:45 PM View: | Gebski Christine See Remarks | Repligen Corp. (RGEN) | 29-Feb-24 | Grant | 391 | -- | -- | 1% 28.79K to 29.18K |